Safety, Tolerability and Pharmacokinetics of the New Formulation SHR-1316 in Subjects With Advanced Tumors
Clinical trial NCT04979390 · UNKNOWN
Trial details
- NCT number
- NCT04979390
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-10
- Primary completion
- 2022-02-10
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.